arrow
J

Julian Großkreutz

department of neurology
H指数:54
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

RIPK1抑制剂SAR443820在肌萎缩侧索硬化症中的安全性、耐受性和有效性(HIMALAYA):一项多中心、随机、双盲、安慰剂对照的2期临床试验

2026-09-090
PRE
Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions

rozanolixizumab在全身性重症肌无力中的长期应用:MycarinG III期研究及两项开放标签扩展研究的最终合并分析

2026-06-290
PRE
Between guidelines and reality: expert neurologists’ perspectives on structural resources for ALS care in Germany

在指南与现实之间:德国专家神经科医生对ALS护理结构资源的看法

2026-04-080
OAAI
Motor phenotypes and neurofilament light chain in genetic amyotrophic lateral sclerosis—results from a multicenter screening program

运动表型与神经丝轻链在遗传性肌萎缩侧索硬化症中的表现——多中心筛查项目的结果

2025-12-120
OA
Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper

肌萎缩侧索硬化症(ALS)临床试验中患者亚组划分的应用价值:世界神经病学联合会白皮书

2025-12-010
PREAI
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen – a multicenter observational study

192例接受nusinersen治疗的脊髓性肌萎缩症(SMA)成年患者的呼吸功能——一项多中心观察性研究

2025-09-290
OA
Response to Fortin-Bédard et al. “User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study”

对Fortin-Bédard等人“在肌萎缩侧索硬化症患者中辅助机械臂的用户期望与体验:一项多中心观察性研究”的回应

2025-09-260
OAAI
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter study

右美沙芬/奎尼丁(DMQ)用于减少肌萎缩侧索硬化症患者的球部症状——多中心研究中治疗经验的评估

2025-09-010
PRE
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis

靶向蛋白质组学在Tofersen治疗中发现与超氧化物歧化酶1相关的肌萎缩侧索硬化症的新型应答标志物

2025-08-090
OAAI
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study

慢性每周罗沙尼利单抗在全身型重症肌无力中的安全性与有效性:随机开放标签扩展MG0004研究

2025-03-190
OA
Small molecule inhibitors of hnRNPA2B1-RNA interactions reveal a predictable sorting of RNA subsets into extracellular vesicles

hnRNPA2B1-RNA相互作用的小分子抑制剂揭示了RNA亚群进入外泌体的可预测性分选

2025-03-180
OA
Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension

周期性罗赞诺利珠单抗在全身型重症肌无力患者中的长期安全性:来自3期MycarinG研究及开放标签扩展研究的结果

2025-03-041
PRE
Provision, cough efficacy and treatment satisfaction of mechanical insufflation-exsufflation in a large multicenter cohort of patients with amyotrophic lateral sclerosis
2025-03-010
OAAI
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data capture

ALS功能评分量表的患者自我评估在智能手机上进行,证明其不劣于临床数据采集。

2025-02-220
OA
Shared prognostic information in amyotrophic lateral sclerosis - systematic assessment of the patients' perception of neurofilament light chain and the ALS functional rating scale

肌萎缩性侧索硬化症的共享预后信息-患者对神经丝轻链的感知和ALS功能评定量表的系统评估

2025-02-060
OAAI
User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study
2024-08-230
OAAI